Porvenir · Engineering for Pharmaceutical & Biotech Companies
App Crashes and Bugs
for
Pharmaceutical & Biotech Companies.
Users are hitting bugs and crashes faster than your team can fix them.
Fixed for pharmaceutical & biotech companies. Pharmaceutical and biotech companies must build scientific credibility and investor confidence simultaneously.
Signs pharmaceutical & biotech companies recognise
Does this sound
familiar?
Why this hits pharmaceutical & biotech companies hardest
Sector-specific
pressure points.
Brand not communicating scientific rigour and clinical credibility to investors and KOLs
No digital strategy for building awareness with HCPs before a product launch
Website failing to explain complex mechanism-of-action in terms stakeholders understand
No content strategy building authority in a competitive therapeutic area
Our approach
How we fix it
for pharmaceutical & biotech companies.
Stability Audit
We review error logs, crash reports, and the codebase to find the root causes behind the most frequent and severe issues.
Fix the Root Cause
We fix the underlying architectural or code-quality issues driving recurring bugs, not just the symptom in front of us.
Testing & Monitoring
We put automated testing and error monitoring in place so future issues are caught before users hit them.
Ongoing Stability
We can continue as an ongoing engineering partner to keep stability high as the product keeps evolving.
What pharmaceutical & biotech companies gain
Real outcomes.
A measurable reduction in crash and bug rate
Testing and monitoring infrastructure that catches issues before launch
A codebase your team can build on confidently going forward
FAQ
Common questions.
Do you specifically fix app crashes and bugs for pharmaceutical & biotech companies?
Yes. We understand the specific commercial context pharmaceutical & biotech companies operate in, and we apply that context directly to how we fix app crashes and bugs.
What causes app crashes and bugs for a pharmaceutical & biotech?
Insufficient automated testing catching regressions before release These issues tend to compound for pharmaceutical & biotech companies because of brand not communicating scientific rigour and clinical credibility to investors and kols.
How quickly can you fix app crashes and bugs for our pharmaceutical & biotech?
Most engagements addressing app crashes and bugs for pharmaceutical & biotech companies show measurable movement within 30–60 days, with the full fix delivered over 4–10 weeks depending on scope.
What results should a pharmaceutical & biotech expect?
A measurable reduction in crash and bug rate Testing and monitoring infrastructure that catches issues before launch
Do you work with pharmaceutical & biotech companies outside our home market?
Yes - we work with pharmaceutical & biotech companies across North America, the UK, UAE, Europe, and Asia Pacific, delivered fully remotely.
Explore more
Related pages.
Other Problems We Solve for Pharmaceutical & Biotech Companies
App Crashes and Bugs for Pharmaceutical & Biotech Companies
Ready to fix
this for your pharmaceutical & biotech?
Book a discovery call. No pitch, no pressure - just a focused conversation about where you are and where you want to be.